GlaxoSmithKline has become the latest big pharma company to disclose payments to healthcare providers, listing 3,700 U.S. doctors and others who received a total of $14.6 million in speaking and consulting fees during the second quarter. Glaxo limits payments to an individual physician to $150,000 a year; the average payment in the report was $3,909. In 2010, it plans to expand what it discloses, the Wall Street Journal Health Blog reports.
